Petros Pharmaceuticals logo

Petros PharmaceuticalsNASDAQ: PTPI

Profile

Sector:

Healthcare

Country:

United States

IPO:

02 December 2020

Next earnings report:

N/A

Last dividends:

N/A

Next dividends:

N/A
$2.57 M
-81%vs. 3y high
6%vs. sector
-vs. 3y high
-vs. sector
-37%vs. 3y high
36%vs. sector
-71%vs. 3y high
16%vs. sector

Price

after hours | 5 min ago
$0.26+$0.01(+2.60%)

Dividend

No data over the past 3 years
$1.58 M$1.28 M
$1.58 M-$2.22 M

Analysts recommendations

Institutional Ownership

PTPI Latest News

Petros Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference
Accesswire06 September 2023 Sentiment: POSITIVE

NEW YORK, NY / ACCESSWIRE / September 6, 2023 / Petros Pharmaceuticals, Inc. (Nasdaq:PTPI), a pioneer in expanding consumer access to medication through over the counter (OTC) pathways, announces today that Fady Boctor, President and Chief Commercial Officer, will present a corporate overview at the H.C. Wainwright 25th Annual Global Investment Conference.

What type of business is Petros Pharmaceuticals?

Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics in the United States and internationally. It operates through two segments, Prescription Medications and Medical Devices. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a novel and patented topical formulation candidate for the treatment of acute Peyronie's disease. The company offers men's health products, including vacuum erection devices, penile injections, PreBoost, VenoSeal, and urinary tract infection tests for the treatment of erectile dysfunction. Petros Pharmaceuticals, Inc. is based in New York, New York.

What sector is Petros Pharmaceuticals in?

Petros Pharmaceuticals is in the Healthcare sector

What industry is Petros Pharmaceuticals in?

Petros Pharmaceuticals is in the Drug Manufacturers - Specialty & Generic industry

What country is Petros Pharmaceuticals from?

Petros Pharmaceuticals is headquartered in United States

When did Petros Pharmaceuticals go public?

Petros Pharmaceuticals initial public offering (IPO) was on 02 December 2020

What is Petros Pharmaceuticals website?

https://www.petrospharma.com

Is Petros Pharmaceuticals in the S&P 500?

No, Petros Pharmaceuticals is not included in the S&P 500 index

Is Petros Pharmaceuticals in the NASDAQ 100?

No, Petros Pharmaceuticals is not included in the NASDAQ 100 index

Is Petros Pharmaceuticals in the Dow Jones?

No, Petros Pharmaceuticals is not included in the Dow Jones index

When was Petros Pharmaceuticals the previous earnings report?

No data

When does Petros Pharmaceuticals earnings report?

Next earnings report date is not announced yet